The abstract is read at the publisher; the summary is JClub's.
The Infectious Disease Knowledge Graph (IDKG) integrates 20 data sources into a Neo4j graph with over 4.6 million nodes and 26 million edges for infectious-disease drug discovery.
- Why it matters: Antiviral and antibacterial discovery is slowed by fragmented biomedical data and antimicrobial resistance, limiting effective repurposing and mechanism-driven hypothesis generation.
- What they did: Using a customized ORION pipeline, IDKG curates chemical, biological, pharmacological, and clinical information and supports graph reasoning via Clinical Outcome Pathways (COPs).
- The result: IDKG enables pathway reconstruction for remdesivir in COVID-19 and mechanistic interpretation of quorum-sensing inhibitor–antibiotic synergies in multidrug-resistant bacteria, supporting repurposing and target prioritization.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.